Patents Assigned to 3P BIOPHARMACEUTICALS, S.L.
  • Alphaviral vectors and cell lines for producing recombinant proteins
    Patent number: 10011847
    Abstract: The present invention relates to polynucleotides and alphaviral vectors for the expression of genes of interest in mammalian cells. Additionally, the invention relates to cells which comprise said polynucleotides and alphaviral vectors and are capable of stably expressing one or more genes of interest. The invention also relates to methods for obtaining said cells, to methods for expressing a gene of interest in said cells, and to methods for replacing the gene of interest stably expressed by said cells with another gene of interest.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: July 3, 2018
    Assignee: 3P BIOPHARMACEUTICALS, S.L.
    Inventors: Alejandro Aranda, Jaione Bezunartea Bezunartea, Cristian Smerdou Picazo, Damaso Molero Sánchez, Edita Mistiene, Andreu Soldevila Fàbrega, Paula Serrano Pérez-Nievas